Kardigan, Inc.
Clinical trials sponsored by Kardigan, Inc., explained in plain language.
-
Experimental heart drug targets inherited heart muscle weakness
Disease control Recruiting nowThis study is testing whether a new medication called danicamtiv can help people with a genetic form of dilated cardiomyopathy, where the heart muscle becomes weak and enlarged. About 332 participants will take either danicamtiv or a placebo pill daily for six months while resear…
Phase: PHASE2, PHASE3 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
New drug trial aims to delay heart valve surgery
Disease control Recruiting nowThis study is testing whether an experimental drug called ataciguat can slow down the progression of moderate aortic valve stenosis, a condition where the heart's main valve narrows and stiffens. Researchers will enroll about 1,276 adults aged 50+ to receive either ataciguat or a…
Phase: PHASE2, PHASE3 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC